NCT00536809View on ClinicalTrials.gov

Phase I/II Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal Cancer

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

September 26, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions

Neoplasms, Colorectal

Interventions

DRUG

lapatinib

onced daily Days 1-21

DRUG

oxaliplatin

Day one of each cycle

DRUG

capecitabine

given BID days 1-14

Trial Locations (1)

53792

GSK Investigational Site, Madison

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY